版本:
中国

BRIEF-iCo Therapeutics says will hold pre IND meeting with division of transplantation & ophthalmology, U.S. FDA

June 15 iCo Therapeutics Inc

* Says it will hold a pre IND meeting with division of transplantation and ophthalmology, US FDA on June 21, 2017

* Says discussions will focus on a proprietary dual action Glaucoma Asset with a Novel mechanism of action that reduces intraocular pressure Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐